Free shipping on all orders over $ 500

Napabucasin (BBI608)

Cat. No. M5807
Napabucasin (BBI608) Structure
Synonym:

BBI608; BB608

Size Price Availability Quantity
5mg USD 60  USD60 In stock
10mg USD 90  USD90 In stock
50mg USD 275  USD275 In stock
100mg USD 480  USD480 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Napabucasin (BBI608) is a first-in-class, orally active inhibitor of Stat3 and cancer cell pluripotency that increases ROS levels through the biological activation of NAD(P) H-quinone dehydrogen1 (NQO1). Napabucasin inhibits the expressions of stemness markers and kill stemness-high cancer cells isolated from several kinds of tumors except PCa. Napabucasin also effectively blocks sphere formation of PrCSCs and kill them as well as inhibits stemness gene expression. Napabucasin inhibits cell proliferation in PC-3 cells and 22RV1 cells at 48, 72, 96, and 120 h (P<0.05).

In vivo, Napabucasin (40 mg/kg) or Docetaxel significantly reduces xenograft tumor growth and tumor volume (TV) compared with PBS (P<0.05). Notably, while no differences are observed between the Napabucasin and the docetaxel groups in PC-3 mouse xenograft models, the TV in Napabucasin group is even lower than docetaxel group in 22RV1 mouse xenograft models (P<0.05).

Chemical Information
Molecular Weight 240.21
Formula C14H8O4
CAS Number 83280-65-3
Solubility (25°C) DMSO 4 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Zhang Y, et al. Cancer Med. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.

Related STAT Products
STAT3-IN-21, cell-permeable, negative control

STAT3-IN-21, cell-permeable, negative control, a peptide, is a negative control for Stat3 activity detection.

STAT3-IN-24, cell-permeable

STAT3-IN-24, cell-permeable (PpYLKTK-mts) is a STAT3 peptide inhibitor.

5-FAM-GpYLPQTV-NH2

5-FAM-GpYLPQTV-NH2 is a fluorescently labeled peptide and has STAT3 inhibitory activity.

Ac-GpYLPQTV-NH2

Ac-GpYLPQTV-NH2 is a STAT3 inhibitor with an IC50 value of 0.33 μM.

XZH-5

XZH-5 inhibits the phosphorylation of STAT3 and results in the induction of apoptosis and reduction of colony forming ability.

  Catalog
Abmole Inhibitor Catalog




Keywords: Napabucasin (BBI608), BBI608; BB608 supplier, STAT, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.